Found: 10
Select item for more details and to access through your institution.
Establishment and Characterization of New Murine Breast Cancer Cell Lines.
- Published in:
- Archiv der Pharmazie, 2002, v. 335, n. 2/3, p. 55, doi. 10.1002/1521-4184(200203)335:2/3<55::AID-ARDP55>3.0.CO;2-Y
- By:
- Publication type:
- Article
Does [meso-1,2-bis(2,6-dichloro-4-hydroxy-phenyl) ethylenediamine]dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound
- Published in:
- Archiv der Pharmazie, 2001, v. 334, n. 10, p. 309, doi. 10.1002/1521-4184(200110)334:10<309::AID-ARDP309>3.0.CO;2-8
- By:
- Publication type:
- Article
1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes - New Biological Response Modifiers for the Therapy of Breast Cancer. Synthesis and Evaluation of Estrogenic/Antiestrogenic Properties.
- Published in:
- Archiv der Pharmazie, 2001, v. 334, n. 4, p. 125, doi. 10.1002/1521-4184(200104)334:4<125::AID-ARDP125>3.0.CO;2-D
- By:
- Publication type:
- Article
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum (II) Act on the Hormone-Sensitive, Murine Breast Cancer as a Biological Response Modifier? Part II. Studies on the Influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the Specific Immune Defense in MXT-M-3,2 Breast Cancer Bearing Mice
- Published in:
- Archiv der Pharmazie, 2000, v. 333, n. 12, p. 397, doi. 10.1002/1521-4184(200012)333:12<397::AID-ARDP397>3.0.CO;2-F
- By:
- Publication type:
- Article
Does [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloro-platinum(II) Act as an Immune Response Modifier? Part III: Progressively Growing MXT-M-3,2 Breast Cancer Stimulates the Proliferation of Phagocytes in B6D2F<sub>1</sub> Mice.
- Published in:
- Archiv der Pharmazie, 2000, v. 333, n. 12, p. 404, doi. 10.1002/1521-4184(200012)333:12<404::AID-ARDP404>3.0.CO;2-M
- By:
- Publication type:
- Article
Part 1: The MXT-M-3.2 Breast Cancer Stimulates the Growth of an Identical Second Graft; [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) Inhibits this Process.
- Published in:
- Archiv der Pharmazie, 2000, v. 333, n. 2/3, p. 69, doi. 10.1002/(SICI)1521-4184(200002)333:2/3<69::AID-ARDP69>3.0.CO;2-D
- By:
- Publication type:
- Article
[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfato-platinum(II) - Pharmacokinetic Studies.
- Published in:
- Archiv der Pharmazie, 1999, v. 332, n. 6, p. 195, doi. 10.1002/(SICI)1521-4184(19996)332:6<195::AID-ARDP195>3.0.CO;2-H
- By:
- Publication type:
- Article
[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a Compound with a Specific Activity on Hormone-Sensitive Breast Cancers - Evidence for a Diethylstilbestrol-Like Mode of Action.
- Published in:
- Archiv der Pharmazie, 1999, v. 332, n. 2, p. 59, doi. 10.1002/(SICI)1521-4184(19993)332:2<59::AID-ARDP59>3.0.CO;2-B
- By:
- Publication type:
- Article
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug-Target Interaction to the Antitumor Activity
- Published in:
- Archiv der Pharmazie, 2004, v. 337, n. 6, p. 349, doi. 10.1002/ardp.200300856
- By:
- Publication type:
- Article
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level.
- Published in:
- Archiv der Pharmazie, 2004, v. 337, n. 6, p. 335, doi. 10.1002/ardp.200300855
- By:
- Publication type:
- Article